Showing results (671-680 of 1,496) with videos related to
Sort By:
Pageof 150
The Journal of Biological Chemistry|February 2, 1996
In situ Ca2+ dependence for activation of Ca2+/calmodulin-dependent protein kinase II in vascular smooth muscle cellsS T Abraham, H Benscoter, C M Schworer, et al.British Journal of Pharmacology|May 1, 1997
Induction by low Na+ or Cl- of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transportersC Pifl, E Agneter, H Drobny, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1989
Characterization of primary T cell subsets mediating rejection of pancreatic islet graftsR G Gill, A S Rosenberg, K J Lafferty, et al.Pharmacology & Therapeutics|December 3, 2014
Epigenetic targets for novel therapies of lung diseasesBrian S Comer, Mariam Ba, Cherie A Singer, et al.British Journal of Obstetrics and Gynaecology|January 1, 1987
Subpopulations of Langerhans' cells in cervical neoplasiaS K Tay, D Jenkins, P Maddox, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1985
Generation of primary murine CTL specific for allogeneic and xenogeneic MHC determinants upon stimulation with murine L cells transfected with class I genesH Golding, J Bluestone, M L Satz, et al.Current Opinion in Oncology|May 25, 2023
Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinomaTaylor Goodstein, Yuanquan Yang, Karie Runcie, et al.Cancers|February 25, 2023
The Impact of COVID-19 on Surgical Training and EducationMelinda Z Fu, Raeesa Islam, Eric A Singer, et al.Technology in Cancer Research & Treatment|March 20, 2023
Examining the Role of Microbiota-Centered Interventions in Cancer Therapeutics: Applications for Urothelial CarcinomaJake C Drobner, Benjamin J Lichtbroun, Eric A Singer, et al.Journal of Kidney Cancer and VHL|October 4, 2023
Systemic Treatment for Advanced and Metastatic Non-Clear Cell Renal Cell Carcinoma: Examining Modern Therapeutic Strategies for a Notoriously Challenging MalignancyJake Drobner, Daniella Portal, Karie Runcie, et al.Pageof 150